Peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy
To evaluate the combined treatment with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from colorectal cancer, pseudomyxoma peritonei and mesothelioma. Data were obtained from 73 patients with peritoneal carcinomatosis arising from colorectal cancer (52....
Saved in:
| Published in: | Journal of Coloproctology Vol. 38; no. 2; pp. 172 - 178 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
Elsevier Editora Ltda
01-06-2018
Thieme Revinter Publicações Ltda |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | To evaluate the combined treatment with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from colorectal cancer, pseudomyxoma peritonei and mesothelioma.
Data were obtained from 73 patients with peritoneal carcinomatosis arising from colorectal cancer (52.1%), pseudomyxoma peritonei (41.1%) or mesothelioma (6.8%) between 2002 and 2011. We reported the morbidity grade (II, III and IV), mortality and survival rates of the candidates after cytoreductive surgery and intraperitoneal chemotherapy.
41 (56.2%) women participated, and the median age was 50 years. Thirty-nine patients (53.4%) underwent complete cytoreductive surgery and intraperitoneal chemotherapy. Patients who underwent a complete cytoreduction received intraperitoneal chemotherapy with mitomycin C, from which only 16/39 (41%) had hyperthermic intraperitoneal chemotherapy (41–42°C). The overall morbidity rate was 23.3% and the grade III/IV complication rate was 12.3%. The overall mortality rate was 5.5%. The univariate analysis showed that cytoreductive surgery and intraperitoneal chemotherapy (p=.029), a blood transfusion (p=.002) and the operative time (p=.001) were significant for the occurrence of postoperative complications. Patients with peritoneal carcinomatosis from colorectal cancer who underwent complete cytoreductive surgery and intraperitoneal chemotherapy had overall survival rates of 81.3%, 12.5% and 12.5% at 1, 3 and 5 years, respectively. Patients with peritoneal carcinomatosis from pseudomyxoma peritonei who underwent complete cytoreductive surgery and intraperitoneal chemotherapy had overall survival rates of 84.2%, 77.7% and 77.7% at 1, 3 and 5 years, respectively.
The combined treatment for peritoneal carcinomatosis may be performed safely with acceptable morbidity and mortality in a specialized unit setting. Although over half of patients underwent normothermic intraperitoneal chemotherapy, our results were comparable to results from others centers.
O objetivo foi avaliar o tratamento combinado da cirurgia citorredutora e quimioterapia intraperitoneal em pacientes com carcinomatose peritoneal secundária ao câncer colorretal, pseudomixoma peritoneal e mesotelioma.
Foram obtidos dados de 73 pacientes com carcinomatose peritoneal secundária ao cirurgia citorredutora (52.1%), pseudomixoma peritoneal (41,1%) ou mesotelioma (6,8%). Foram avaliados o grau de morbidade, a taxa de mortalidade e as taxas de sobrevida após a cirurgia citorredutora e quimioterapia intraperitoneal.
41 (56,2%) pacientes do sexo feminino participaram, com média de idade de 50 anos. 39 pacientes (53,4%) foram submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal. Todos esses receberam Mitomicina C, sendo 16/39 (41%) quimioterapia intraperitoneal hipertérmica (41–42°C). A morbidade global foi 23,3%, com taxa de mortalidade global de 5,5%. A análise univariada mostrou que câncer colorretal e quimioterapia intraperitoneal (p = .029), transfusão sanguínea (p = .002) e tempo operatório (p = .001) foram associados com complicações pós-operatórias. Pacientes com carcinomatose peritoneal secundária ao cirurgia citorredutora submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal tiveram sobrevida global de 81,3%; 12,5% e 12,5% em 1, 3 e 5 anos, respectivamente. Os pacientes com pseudomixoma peritoneal que foram submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal tiveram sobrevida global de 84,2%; 77,7% e 77.7% em 1, 3 e 5 anos, respectivamente.
O tratamento combinado para carcinomatose peritoneal é seguro quando realizado em centros terciários com experiência no procedimento. Embora mais da metade dos pacientes tenham sido submetidos a quimioterapia intraperitoneal normotérmica após a cirurgia citorredutora completa, os resultados podem ser comparados a de outros centros que utilizam exclusivamente a quimioterapia hipertérmica. |
|---|---|
| AbstractList | Abstract
Introduction
To evaluate the combined treatment with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from colorectal cancer, pseudomyxoma peritonei and mesothelioma.
Methods
Data were obtained from 73 patients with peritoneal carcinomatosis arising from colorectal cancer (52.1%), pseudomyxoma peritonei (41.1%) or mesothelioma (6.8%) between 2002 and 2011. We reported the morbidity grade (II, III and IV), mortality and survival rates of the candidates after cytoreductive surgery and intraperitoneal chemotherapy.
Results
41 (56.2%) women participated, and the median age was 50 years. Thirty-nine patients (53.4%) underwent complete cytoreductive surgery and intraperitoneal chemotherapy. Patients who underwent a complete cytoreduction received intraperitoneal chemotherapy with mitomycin C, from which only 16/39 (41%) had hyperthermic intraperitoneal chemotherapy (41–42 °C). The overall morbidity rate was 23.3% and the grade III/IV complication rate was 12.3%. The overall mortality rate was 5.5%. The univariate analysis showed that cytoreductive surgery and intraperitoneal chemotherapy (
p
= .029), a blood transfusion (
p
= .002) and the operative time (
p
= .001) were significant for the occurrence of postoperative complications. Patients with peritoneal carcinomatosis from colorectal cancer who underwent complete cytoreductive surgery and intraperitoneal chemotherapy had overall survival rates of 81.3%, 12.5% and 12.5% at 1, 3 and 5 years, respectively. Patients with peritoneal carcinomatosis from pseudomyxoma peritonei who underwent complete cytoreductive surgery and intraperitoneal chemotherapy had overall survival rates of 84.2%, 77.7% and 77.7% at 1, 3 and 5 years, respectively.
Conclusion
The combined treatment for peritoneal carcinomatosis may be performed safely with acceptable morbidity and mortality in a specialized unit setting. Although over half of patients underwent normothermic intraperitoneal chemotherapy, our results were comparable to results from others centers. Introduction To evaluate the combined treatment with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from colorectal cancer, pseudomyxoma peritonei and mesothelioma. Methods Data were obtained from 73 patients with peritoneal carcinomatosis arising from colorectal cancer (52.1%), pseudomyxoma peritonei (41.1%) or mesothelioma (6.8%) between 2002 and 2011. We reported the morbidity grade (II, III and IV), mortality and survival rates of the candidates after cytoreductive surgery and intraperitoneal chemotherapy. Results 41 (56.2%) women participated, and the median age was 50 years. Thirty-nine patients (53.4%) underwent complete cytoreductive surgery and intraperitoneal chemotherapy. Patients who underwent a complete cytoreduction received intraperitoneal chemotherapy with mitomycin C, from which only 16/39 (41%) had hyperthermic intraperitoneal chemotherapy (41–42 °C). The overall morbidity rate was 23.3% and the grade III/IV complication rate was 12.3%. The overall mortality rate was 5.5%. The univariate analysis showed that cytoreductive surgery and intraperitoneal chemotherapy (p = .029), a blood transfusion (p = .002) and the operative time (p = .001) were significant for the occurrence of postoperative complications. Patients with peritoneal carcinomatosis from colorectal cancer who underwent complete cytoreductive surgery and intraperitoneal chemotherapy had overall survival rates of 81.3%, 12.5% and 12.5% at 1, 3 and 5 years, respectively. Patients with peritoneal carcinomatosis from pseudomyxoma peritonei who underwent complete cytoreductive surgery and intraperitoneal chemotherapy had overall survival rates of 84.2%, 77.7% and 77.7% at 1, 3 and 5 years, respectively. Conclusion The combined treatment for peritoneal carcinomatosis may be performed safely with acceptable morbidity and mortality in a specialized unit setting. Although over half of patients underwent normothermic intraperitoneal chemotherapy, our results were comparable to results from others centers. To evaluate the combined treatment with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from colorectal cancer, pseudomyxoma peritonei and mesothelioma. Data were obtained from 73 patients with peritoneal carcinomatosis arising from colorectal cancer (52.1%), pseudomyxoma peritonei (41.1%) or mesothelioma (6.8%) between 2002 and 2011. We reported the morbidity grade (II, III and IV), mortality and survival rates of the candidates after cytoreductive surgery and intraperitoneal chemotherapy. 41 (56.2%) women participated, and the median age was 50 years. Thirty-nine patients (53.4%) underwent complete cytoreductive surgery and intraperitoneal chemotherapy. Patients who underwent a complete cytoreduction received intraperitoneal chemotherapy with mitomycin C, from which only 16/39 (41%) had hyperthermic intraperitoneal chemotherapy (41–42°C). The overall morbidity rate was 23.3% and the grade III/IV complication rate was 12.3%. The overall mortality rate was 5.5%. The univariate analysis showed that cytoreductive surgery and intraperitoneal chemotherapy (p=.029), a blood transfusion (p=.002) and the operative time (p=.001) were significant for the occurrence of postoperative complications. Patients with peritoneal carcinomatosis from colorectal cancer who underwent complete cytoreductive surgery and intraperitoneal chemotherapy had overall survival rates of 81.3%, 12.5% and 12.5% at 1, 3 and 5 years, respectively. Patients with peritoneal carcinomatosis from pseudomyxoma peritonei who underwent complete cytoreductive surgery and intraperitoneal chemotherapy had overall survival rates of 84.2%, 77.7% and 77.7% at 1, 3 and 5 years, respectively. The combined treatment for peritoneal carcinomatosis may be performed safely with acceptable morbidity and mortality in a specialized unit setting. Although over half of patients underwent normothermic intraperitoneal chemotherapy, our results were comparable to results from others centers. O objetivo foi avaliar o tratamento combinado da cirurgia citorredutora e quimioterapia intraperitoneal em pacientes com carcinomatose peritoneal secundária ao câncer colorretal, pseudomixoma peritoneal e mesotelioma. Foram obtidos dados de 73 pacientes com carcinomatose peritoneal secundária ao cirurgia citorredutora (52.1%), pseudomixoma peritoneal (41,1%) ou mesotelioma (6,8%). Foram avaliados o grau de morbidade, a taxa de mortalidade e as taxas de sobrevida após a cirurgia citorredutora e quimioterapia intraperitoneal. 41 (56,2%) pacientes do sexo feminino participaram, com média de idade de 50 anos. 39 pacientes (53,4%) foram submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal. Todos esses receberam Mitomicina C, sendo 16/39 (41%) quimioterapia intraperitoneal hipertérmica (41–42°C). A morbidade global foi 23,3%, com taxa de mortalidade global de 5,5%. A análise univariada mostrou que câncer colorretal e quimioterapia intraperitoneal (p = .029), transfusão sanguínea (p = .002) e tempo operatório (p = .001) foram associados com complicações pós-operatórias. Pacientes com carcinomatose peritoneal secundária ao cirurgia citorredutora submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal tiveram sobrevida global de 81,3%; 12,5% e 12,5% em 1, 3 e 5 anos, respectivamente. Os pacientes com pseudomixoma peritoneal que foram submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal tiveram sobrevida global de 84,2%; 77,7% e 77.7% em 1, 3 e 5 anos, respectivamente. O tratamento combinado para carcinomatose peritoneal é seguro quando realizado em centros terciários com experiência no procedimento. Embora mais da metade dos pacientes tenham sido submetidos a quimioterapia intraperitoneal normotérmica após a cirurgia citorredutora completa, os resultados podem ser comparados a de outros centros que utilizam exclusivamente a quimioterapia hipertérmica. Introduction: To evaluate the combined treatment with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from colorectal cancer, pseudomyxoma peritonei and mesothelioma. Methods: Data were obtained from 73 patients with peritoneal carcinomatosis arising from colorectal cancer (52.1%), pseudomyxoma peritonei (41.1%) or mesothelioma (6.8%) between 2002 and 2011. We reported the morbidity grade (II, III and IV), mortality and survival rates of the candidates after cytoreductive surgery and intraperitoneal chemotherapy. Results: 41 (56.2%) women participated, and the median age was 50 years. Thirty-nine patients (53.4%) underwent complete cytoreductive surgery and intraperitoneal chemotherapy. Patients who underwent a complete cytoreduction received intraperitoneal chemotherapy with mitomycin C, from which only 16/39 (41%) had hyperthermic intraperitoneal chemotherapy (41–42 °C). The overall morbidity rate was 23.3% and the grade III/IV complication rate was 12.3%. The overall mortality rate was 5.5%. The univariate analysis showed that cytoreductive surgery and intraperitoneal chemotherapy (p = .029), a blood transfusion (p = .002) and the operative time (p = .001) were significant for the occurrence of postoperative complications. Patients with peritoneal carcinomatosis from colorectal cancer who underwent complete cytoreductive surgery and intraperitoneal chemotherapy had overall survival rates of 81.3%, 12.5% and 12.5% at 1, 3 and 5 years, respectively. Patients with peritoneal carcinomatosis from pseudomyxoma peritonei who underwent complete cytoreductive surgery and intraperitoneal chemotherapy had overall survival rates of 84.2%, 77.7% and 77.7% at 1, 3 and 5 years, respectively. Conclusion: The combined treatment for peritoneal carcinomatosis may be performed safely with acceptable morbidity and mortality in a specialized unit setting. Although over half of patients underwent normothermic intraperitoneal chemotherapy, our results were comparable to results from others centers. Resumo: Introdução: O objetivo foi avaliar o tratamento combinado da cirurgia citorredutora e quimioterapia intraperitoneal em pacientes com carcinomatose peritoneal secundária ao câncer colorretal, pseudomixoma peritoneal e mesotelioma. Métodos: Foram obtidos dados de 73 pacientes com carcinomatose peritoneal secundária ao cirurgia citorredutora (52.1%), pseudomixoma peritoneal (41,1%) ou mesotelioma (6,8%). Foram avaliados o grau de morbidade, a taxa de mortalidade e as taxas de sobrevida após a cirurgia citorredutora e quimioterapia intraperitoneal. Resultados: 41 (56,2%) pacientes do sexo feminino participaram, com média de idade de 50 anos. 39 pacientes (53,4%) foram submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal. Todos esses receberam Mitomicina C, sendo 16/39 (41%) quimioterapia intraperitoneal hipertérmica (41–42°C). A morbidade global foi 23,3%, com taxa de mortalidade global de 5,5%. A análise univariada mostrou que câncer colorretal e quimioterapia intraperitoneal (p = .029), transfusão sanguínea (p = .002) e tempo operatório (p = .001) foram associados com complicações pós-operatórias. Pacientes com carcinomatose peritoneal secundária ao cirurgia citorredutora submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal tiveram sobrevida global de 81,3%; 12,5% e 12,5% em 1, 3 e 5 anos, respectivamente. Os pacientes com pseudomixoma peritoneal que foram submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal tiveram sobrevida global de 84,2%; 77,7% e 77.7% em 1, 3 e 5 anos, respectivamente. Conclusão: O tratamento combinado para carcinomatose peritoneal é seguro quando realizado em centros terciários com experiência no procedimento. Embora mais da metade dos pacientes tenham sido submetidos a quimioterapia intraperitoneal normotérmica após a cirurgia citorredutora completa, os resultados podem ser comparados a de outros centros que utilizam exclusivamente a quimioterapia hipertérmica. Keywords: Cytoreductive surgery, Intraperitoneal chemotherapy, Peritoneal carcinomatosis, Colorectal cancer, Pseudomyxoma peritonei, Palavras-chave: Cirurgia citorredutora, Quimioterapia intraperitoneal, Carcinomatose peritoneal, Cancer colorretal, Pseudomixoma peritoneal |
| Abstract_FL | Resumo
Introdução
O objetivo foi avaliar o tratamento combinado da cirurgia citorredutora e quimioterapia intraperitoneal em pacientes com carcinomatose peritoneal secundária ao câncer colorretal, pseudomixoma peritoneal e mesotelioma.
Métodos
Foram obtidos dados de 73 pacientes com carcinomatose peritoneal secundária ao cirurgia citorredutora (52.1%), pseudomixoma peritoneal (41,1%) ou mesotelioma (6,8%). Foram avaliados o grau de morbidade, a taxa de mortalidade e as taxas de sobrevida após a cirurgia citorredutora e quimioterapia intraperitoneal.
Resultados
41 (56,2%) pacientes do sexo feminino participaram, com média de idade de 50 anos. 39 pacientes (53,4%) foram submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal. Todos esses receberam Mitomicina C, sendo 16/39 (41%) quimioterapia intraperitoneal hipertérmica (41–42°C). A morbidade global foi 23,3%, com taxa de mortalidade global de 5,5%. A análise univariada mostrou que câncer colorretal e quimioterapia intraperitoneal (p = .029), transfusão sanguínea (p = .002) e tempo operatório (p = .001) foram associados com complicações pós-operatórias. Pacientes com carcinomatose peritoneal secundária ao cirurgia citorredutora submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal tiveram sobrevida global de 81,3%; 12,5% e 12,5% em 1, 3 e 5 anos, respectivamente. Os pacientes com pseudomixoma peritoneal que foram submetidos a cirurgia citorredutora completa e quimioterapia intraperitoneal tiveram sobrevida global de 84,2%; 77,7% e 77.7% em 1, 3 e 5 anos, respectivamente.
Conclusão
O tratamento combinado para carcinomatose peritoneal é seguro quando realizado em centros terciários com experiência no procedimento. Embora mais da metade dos pacientes tenham sido submetidos a quimioterapia intraperitoneal normotérmica após a cirurgia citorredutora completa, os resultados podem ser comparados a de outros centros que utilizam exclusivamente a quimioterapia hipertérmica. |
| Author | Lacerda-Filho, Antônio Profeta da Luz, Magda Maria Hanan, Bernardo Fonseca, Leonardo Maciel Gomes da Silva, Rodrigo Cabral, Mônica Maria Demas Álvares |
| Author_xml | – sequence: 1 givenname: Bernardo surname: Hanan fullname: Hanan, Bernardo organization: Universidade Federal de Minas Gerais (UFMG), Hospital das Clínicas, Instituto Alfa de Gastroenterologia, Belo Horizonte, MG, Brazil – sequence: 2 givenname: Leonardo Maciel surname: Fonseca fullname: Fonseca, Leonardo Maciel organization: Universidade Federal de Minas Gerais (UFMG), Hospital das Clínicas, Instituto Alfa de Gastroenterologia, Belo Horizonte, MG, Brazil – sequence: 3 givenname: Magda Maria surname: Profeta da Luz fullname: Profeta da Luz, Magda Maria organization: Universidade Federal de Minas Gerais (UFMG), Hospital das Clínicas, Instituto Alfa de Gastroenterologia, Belo Horizonte, MG, Brazil – sequence: 4 givenname: Antônio surname: Lacerda-Filho fullname: Lacerda-Filho, Antônio organization: Universidade Federal de Minas Gerais (UFMG), Hospital das Clínicas, Instituto Alfa de Gastroenterologia, Belo Horizonte, MG, Brazil – sequence: 5 givenname: Mônica Maria Demas Álvares surname: Cabral fullname: Cabral, Mônica Maria Demas Álvares organization: Universidade Federal de Minas Gerais (UFMG), Hospital das Clínicas, Instituto Alfa de Gastroenterologia, Belo Horizonte, MG, Brazil – sequence: 6 givenname: Rodrigo surname: Gomes da Silva fullname: Gomes da Silva, Rodrigo email: rodrigogsilva@uol.com.br organization: Universidade Federal de Minas Gerais (UFMG), Hospital das Clínicas, Instituto Alfa de Gastroenterologia, Belo Horizonte, MG, Brazil |
| BookMark | eNp9kNFqHCEUQCWkkDTJD_RpfmCmXt1RB_pSQtssBJKH5DHIHb2bddgdg7op-_d1syXkKb4oF89Bz1d2OseZGPsGvAMO6vvUTS5uOsFBdwAd5-qEnQsJulULIU_rWUjdDlLJM3aV88TrUn29rs7Z0z2lUKoPN43D5MIct1hiDrkpibCQb_6Gsm7cvsREfudKeKUm79IzpX2Ds2_CXBK-fLCsaRvLmupwf8m-rHCT6er_fsEef_96uL5pb-_-LK9_3rZO9lq10nDNsV8prlTvhRuMVmMPgsAIo8QgNZF3i3E0wLVSK6FHb4zXhMDlCCgv2PLo9REn-5LCFtPeRgz2bRDTs8VUgtuQHZDQ0eCAK1hoh8bASMogJ4MgyVWXOLpcijknWr37gNtDbzvZQ2976G0BbI1ZIThCZR1oS3aKuzTXH3_O_DgyVMu8Bko2u0CzIx8SuVKfHj7D_wFKv5zA |
| Cites_doi | 10.1007/s004230050246 10.1200/JCO.2011.39.7166 10.1245/s10434-009-0487-4 10.1002/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R 10.1200/JCO.2009.23.9285 10.1245/ASO.2004.09.008 10.1111/j.1445-2197.2006.03684.x 10.1245/ASO.2004.05.009 10.1007/s00268-008-9880-6 10.1093/annonc/mdf019 10.1097/SLA.0b013e31818a15b5 10.1007/s00268-009-0206-0 10.1016/j.jamcollsurg.2006.08.024 10.1001/archsurg.139.1.20 10.1002/cncr.25116 10.1155/2012/836425 10.1186/1471-2407-6-162 10.1055/s-2005-916280 10.1093/annonc/mdh186 10.1007/BF01274232 10.1007/BF02236627 10.1001/archsurg.138.1.26 10.1055/s-2005-916281 |
| ContentType | Journal Article |
| Copyright | 2018 Sociedade Brasileira de Coloproctologia Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. |
| Copyright_xml | – notice: 2018 Sociedade Brasileira de Coloproctologia – notice: Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. |
| DBID | 6I. AAFTH 0U6 AAYXX CITATION DOA |
| DOI | 10.1016/j.jcol.2017.11.006 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Thieme Connect Journals Open Access CrossRef Directory of Open Access Journals |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Carcinomatose peritoneal tratada com cirurgia citoreductiva e quimioterapia intraperitoneal |
| DocumentTitle_FL | Carcinomatose peritoneal tratada com cirurgia citoreductiva e quimioterapia intraperitoneal |
| EISSN | 2317-6423 |
| EndPage | 178 |
| ExternalDocumentID | oai_doaj_org_article_9aeace9c106147ca881be68a0e8a13ec 10_1016_j_jcol_2017_11_006 S2237936317305762 |
| GroupedDBID | .1- .FO 0SF 0U6 1P~ 4.4 457 5VS 6I. AACTN AAEDT AAEDW AAFTH AAIKJ AALRI AAXUO ABMAC ACGFS ADBBV ADCUG ADEZE AEVXI AEXQZ AFCTW AFRHN AFTJW AGHFR AITUG AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ APOWU AZFZN BAWUL BCNDV DIK EBS EJD FDB FNPLU GROUPED_DOAJ IPNFZ IXB KQ8 LCYCR M41 NCXOZ OC. OK1 ON0 RIG RNS ROL RSC RTC SSZ Z5R 0R~ ADVLN AHRAW AKRWK AAYXX CITATION |
| ID | FETCH-LOGICAL-c3576-38070a5f60665d2c9876b512e182862937eedc4bb810766f27bd88d7ea103b1a3 |
| IEDL.DBID | DOA |
| ISSN | 2237-9363 |
| IngestDate | Tue Oct 22 15:09:20 EDT 2024 Thu Nov 21 21:46:28 EST 2024 Sun Nov 24 15:09:33 EST 2024 Thu Jul 20 20:06:36 EDT 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Pseudomixoma peritoneal Carcinomatose peritoneal Cytoreductive surgery Intraperitoneal chemotherapy Peritoneal carcinomatosis Colorectal cancer Cancer colorretal Cirurgia citorredutora Pseudomyxoma peritonei Quimioterapia intraperitoneal |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. CC BY-NC-ND 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3576-38070a5f60665d2c9876b512e182862937eedc4bb810766f27bd88d7ea103b1a3 |
| OpenAccessLink | https://doaj.org/article/9aeace9c106147ca881be68a0e8a13ec |
| PageCount | 7 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_9aeace9c106147ca881be68a0e8a13ec crossref_primary_10_1016_j_jcol_2017_11_006 thieme_journals_10_1016_j_jcol_2017_11_006 elsevier_sciencedirect_doi_10_1016_j_jcol_2017_11_006 |
| PublicationCentury | 2000 |
| PublicationDate | 20180600 |
| PublicationDateYYYYMMDD | 2018-06-01 |
| PublicationDate_xml | – month: 06 year: 2018 text: 20180600 |
| PublicationDecade | 2010 |
| PublicationPlace | Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil |
| PublicationPlace_xml | – name: Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil |
| PublicationTitle | Journal of Coloproctology |
| PublicationYear | 2018 |
| Publisher | Elsevier Editora Ltda Thieme Revinter Publicações Ltda |
| Publisher_xml | – name: Elsevier Editora Ltda – name: Thieme Revinter Publicações Ltda |
| References | Clavien, Sanabria, Strasberg (bib0175) 1992; 111 Yan, Morris (bib0220) 2008; 248 Sugarbaker (bib0155) 1999; 384 Elias, Bonnay, Puizillou, Antoun, Demirdjian, El (bib0165) 2002; 13 Pelz, Doerfer, Dimmler, Hohenberger, Meyer (bib0225) 2004; 6 Akaishi, Teixeira, Katayama, Mizumoto, Costa, Buzaid (bib0260) 2009; 33 Sugarbaker (bib0195) 2005; 18 Mizumoto, Canbay, Hirano, Takao, Matsuda, Ichinose (bib0240) 2012; 2012 Chua, Moran, Sugarbaker, Levine, Glehen, Gilly (bib0200) 2012; 30 Shen, Hawksworth, Lovato, Loggie, Geisinger, Fleming (bib0215) 2004; 11 Sugarbaker (bib0135) 1989; 32 Elias, Gilly, Boutitie, Quenet, Bereder, Mansvelt (bib0255) 2010; 28 Elias, Delperro, Sideris, Benhamou, Pocard, Baton (bib0205) 2004; 11 Sugarbaker (bib0140) 2005; 18 Pestieau, Sugarbaker (bib0190) 2000; 43 Cavaliere, Valle, De Simone, Deraco, Rossi, Di Filippo (bib0150) 2006; 20 Glehen, Schreiber, Cotte, Sayag-Beaujard, Osinsky, Freyer (bib0185) 2004; 139 Shen, Levine, Hall, Case, Russell, Fleming (bib0245) 2003; 138 Sugarbaker (bib0145) 2006; 76 Ronnett, Yan, Kurman, Shmookler, Wu, Sugarbaker (bib0160) 2001; 92 Franko, Ibrahim, Gusani, Holtzman, Bartlett, Zeh (bib0210) 2010; 116 Elias, Sideris, Pocard, Edè, Ben Hassouna, Ducreux (bib0230) 2004; 215 Sugarbaker (bib0235) 1988; 373 Saxena, Yan, Morris (bib0250) 2010; 34 Cao, Yan, Black, Morris (bib0180) 2009; 16 da Silva, Sugarbaker (bib0170) 2006; 203 Sugarbaker (10.1016/j.jcol.2017.11.006_bib0145) 2006; 76 Ronnett (10.1016/j.jcol.2017.11.006_bib0160) 2001; 92 Saxena (10.1016/j.jcol.2017.11.006_bib0250) 2010; 34 Cavaliere (10.1016/j.jcol.2017.11.006_bib0150) 2006; 20 Sugarbaker (10.1016/j.jcol.2017.11.006_bib0195) 2005; 18 Sugarbaker (10.1016/j.jcol.2017.11.006_bib0155) 1999; 384 Clavien (10.1016/j.jcol.2017.11.006_bib0175) 1992; 111 Yan (10.1016/j.jcol.2017.11.006_bib0220) 2008; 248 Mizumoto (10.1016/j.jcol.2017.11.006_bib0240) 2012; 2012 Elias (10.1016/j.jcol.2017.11.006_bib0165) 2002; 13 Elias (10.1016/j.jcol.2017.11.006_bib0230) 2004; 215 Elias (10.1016/j.jcol.2017.11.006_bib0255) 2010; 28 Akaishi (10.1016/j.jcol.2017.11.006_bib0260) 2009; 33 Sugarbaker (10.1016/j.jcol.2017.11.006_bib0135) 1989; 32 da Silva (10.1016/j.jcol.2017.11.006_bib0170) 2006; 203 Sugarbaker (10.1016/j.jcol.2017.11.006_bib0235) 1988; 373 Franko (10.1016/j.jcol.2017.11.006_bib0210) 2010; 116 Chua (10.1016/j.jcol.2017.11.006_bib0200) 2012; 30 Elias (10.1016/j.jcol.2017.11.006_bib0205) 2004; 11 Pelz (10.1016/j.jcol.2017.11.006_bib0225) 2004; 6 Glehen (10.1016/j.jcol.2017.11.006_bib0185) 2004; 139 Shen (10.1016/j.jcol.2017.11.006_bib0245) 2003; 138 Pestieau (10.1016/j.jcol.2017.11.006_bib0190) 2000; 43 Shen (10.1016/j.jcol.2017.11.006_bib0215) 2004; 11 Cao (10.1016/j.jcol.2017.11.006_bib0180) 2009; 16 Sugarbaker (10.1016/j.jcol.2017.11.006_bib0140) 2005; 18 |
| References_xml | – volume: 28 start-page: 63 year: 2010 end-page: 68 ident: bib0255 article-title: Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study publication-title: J Clin Oncol contributor: fullname: Mansvelt – volume: 248 start-page: 829 year: 2008 end-page: 835 ident: bib0220 article-title: Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? publication-title: Ann Surg contributor: fullname: Morris – volume: 6 start-page: 162 year: 2004 ident: bib0225 article-title: Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations publication-title: BMC Cancer contributor: fullname: Meyer – volume: 384 start-page: 576 year: 1999 end-page: 587 ident: bib0155 article-title: Management of peritoneal-surface malignancy: the surgeon's role publication-title: Langenbecks Arch Surg contributor: fullname: Sugarbaker – volume: 11 start-page: 518 year: 2004 end-page: 521 ident: bib0205 article-title: Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials publication-title: Ann Surg Oncol contributor: fullname: Baton – volume: 138 start-page: 26 year: 2003 end-page: 33 ident: bib0245 article-title: Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis publication-title: Arch Surg contributor: fullname: Fleming – volume: 18 start-page: 190 year: 2005 end-page: 203 ident: bib0140 article-title: Surgical management of carcinomatosis from colorectal cancer publication-title: Clin Colon Rectal Surg contributor: fullname: Sugarbaker – volume: 13 start-page: 267 year: 2002 end-page: 272 ident: bib0165 article-title: Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution publication-title: Ann Oncol contributor: fullname: El – volume: 16 start-page: 2152 year: 2009 end-page: 2165 ident: bib0180 article-title: A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin publication-title: Ann Surg Oncol contributor: fullname: Morris – volume: 32 start-page: 164 year: 1989 end-page: 170 ident: bib0135 article-title: Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture publication-title: Can J Surg contributor: fullname: Sugarbaker – volume: 116 start-page: 3756 year: 2010 end-page: 3762 ident: bib0210 article-title: Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis publication-title: Cancer contributor: fullname: Zeh – volume: 43 start-page: 1341 year: 2000 end-page: 1346 ident: bib0190 article-title: Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management publication-title: Dis Colon Rectum contributor: fullname: Sugarbaker – volume: 30 start-page: 2449 year: 2012 end-page: 2456 ident: bib0200 article-title: Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy publication-title: J Clin Oncol contributor: fullname: Gilly – volume: 20 start-page: 747 year: 2006 end-page: 750 ident: bib0150 article-title: 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study publication-title: In Vivo contributor: fullname: Di Filippo – volume: 33 start-page: 835 year: 2009 end-page: 839 ident: bib0260 article-title: Peritonectomy for peritoneal carcinomatosis: long-term outcomes from a single Brazilian institution publication-title: World J Surg contributor: fullname: Buzaid – volume: 203 start-page: 878 year: 2006 end-page: 886 ident: bib0170 article-title: Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer publication-title: J Am Coll Surg contributor: fullname: Sugarbaker – volume: 215 start-page: 781 year: 2004 end-page: 785 ident: bib0230 article-title: Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients publication-title: Ann Oncol contributor: fullname: Ducreux – volume: 76 start-page: 62 year: 2006 ident: bib0145 article-title: Evolving strategies for surgical management of carcinomatosis publication-title: ANZ J Surg contributor: fullname: Sugarbaker – volume: 92 start-page: 85 year: 2001 end-page: 91 ident: bib0160 article-title: Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis publication-title: Cancer contributor: fullname: Sugarbaker – volume: 139 start-page: 20 year: 2004 end-page: 26 ident: bib0185 article-title: Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer publication-title: Arch Surg contributor: fullname: Freyer – volume: 11 start-page: 178 year: 2004 end-page: 186 ident: bib0215 article-title: Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma publication-title: Ann Surg Oncol contributor: fullname: Fleming – volume: 373 start-page: 189 year: 1988 end-page: 196 ident: bib0235 article-title: Surgical management of peritoneal carcinosis: diagnosis, prevention and treatment publication-title: Langenbecks Arch Chir contributor: fullname: Sugarbaker – volume: 111 start-page: 518 year: 1992 end-page: 526 ident: bib0175 article-title: Proposed classification of complications of surgery with examples of utility in cholecystectomy publication-title: Surgery contributor: fullname: Strasberg – volume: 2012 start-page: 836425 year: 2012 ident: bib0240 article-title: Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan publication-title: Gastroenterol Res Pract contributor: fullname: Ichinose – volume: 18 start-page: 204 year: 2005 end-page: 214 ident: bib0195 article-title: Cytoreductive surgery and perioperative intraperitoneal chemotherapy: a new standard of care for appendiceal mucinous tumors with peritoneal dissemination publication-title: Clin Colon Rectal Surg contributor: fullname: Sugarbaker – volume: 34 start-page: 70 year: 2010 end-page: 78 ident: bib0250 article-title: A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis publication-title: World J Surg contributor: fullname: Morris – volume: 384 start-page: 576 year: 1999 ident: 10.1016/j.jcol.2017.11.006_bib0155 article-title: Management of peritoneal-surface malignancy: the surgeon's role publication-title: Langenbecks Arch Surg doi: 10.1007/s004230050246 contributor: fullname: Sugarbaker – volume: 30 start-page: 2449 year: 2012 ident: 10.1016/j.jcol.2017.11.006_bib0200 article-title: Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy publication-title: J Clin Oncol doi: 10.1200/JCO.2011.39.7166 contributor: fullname: Chua – volume: 16 start-page: 2152 year: 2009 ident: 10.1016/j.jcol.2017.11.006_bib0180 article-title: A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin publication-title: Ann Surg Oncol doi: 10.1245/s10434-009-0487-4 contributor: fullname: Cao – volume: 92 start-page: 85 year: 2001 ident: 10.1016/j.jcol.2017.11.006_bib0160 article-title: Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis publication-title: Cancer doi: 10.1002/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R contributor: fullname: Ronnett – volume: 28 start-page: 63 year: 2010 ident: 10.1016/j.jcol.2017.11.006_bib0255 article-title: Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study publication-title: J Clin Oncol doi: 10.1200/JCO.2009.23.9285 contributor: fullname: Elias – volume: 11 start-page: 518 year: 2004 ident: 10.1016/j.jcol.2017.11.006_bib0205 article-title: Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials publication-title: Ann Surg Oncol doi: 10.1245/ASO.2004.09.008 contributor: fullname: Elias – volume: 76 start-page: 62 year: 2006 ident: 10.1016/j.jcol.2017.11.006_bib0145 article-title: Evolving strategies for surgical management of carcinomatosis publication-title: ANZ J Surg doi: 10.1111/j.1445-2197.2006.03684.x contributor: fullname: Sugarbaker – volume: 11 start-page: 178 year: 2004 ident: 10.1016/j.jcol.2017.11.006_bib0215 article-title: Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma publication-title: Ann Surg Oncol doi: 10.1245/ASO.2004.05.009 contributor: fullname: Shen – volume: 33 start-page: 835 year: 2009 ident: 10.1016/j.jcol.2017.11.006_bib0260 article-title: Peritonectomy for peritoneal carcinomatosis: long-term outcomes from a single Brazilian institution publication-title: World J Surg doi: 10.1007/s00268-008-9880-6 contributor: fullname: Akaishi – volume: 13 start-page: 267 year: 2002 ident: 10.1016/j.jcol.2017.11.006_bib0165 article-title: Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution publication-title: Ann Oncol doi: 10.1093/annonc/mdf019 contributor: fullname: Elias – volume: 248 start-page: 829 year: 2008 ident: 10.1016/j.jcol.2017.11.006_bib0220 article-title: Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? publication-title: Ann Surg doi: 10.1097/SLA.0b013e31818a15b5 contributor: fullname: Yan – volume: 34 start-page: 70 year: 2010 ident: 10.1016/j.jcol.2017.11.006_bib0250 article-title: A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis publication-title: World J Surg doi: 10.1007/s00268-009-0206-0 contributor: fullname: Saxena – volume: 203 start-page: 878 year: 2006 ident: 10.1016/j.jcol.2017.11.006_bib0170 article-title: Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer publication-title: J Am Coll Surg doi: 10.1016/j.jamcollsurg.2006.08.024 contributor: fullname: da Silva – volume: 139 start-page: 20 year: 2004 ident: 10.1016/j.jcol.2017.11.006_bib0185 article-title: Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer publication-title: Arch Surg doi: 10.1001/archsurg.139.1.20 contributor: fullname: Glehen – volume: 116 start-page: 3756 year: 2010 ident: 10.1016/j.jcol.2017.11.006_bib0210 article-title: Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis publication-title: Cancer doi: 10.1002/cncr.25116 contributor: fullname: Franko – volume: 2012 start-page: 836425 year: 2012 ident: 10.1016/j.jcol.2017.11.006_bib0240 article-title: Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan publication-title: Gastroenterol Res Pract doi: 10.1155/2012/836425 contributor: fullname: Mizumoto – volume: 6 start-page: 162 year: 2004 ident: 10.1016/j.jcol.2017.11.006_bib0225 article-title: Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations publication-title: BMC Cancer doi: 10.1186/1471-2407-6-162 contributor: fullname: Pelz – volume: 32 start-page: 164 year: 1989 ident: 10.1016/j.jcol.2017.11.006_bib0135 article-title: Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture publication-title: Can J Surg contributor: fullname: Sugarbaker – volume: 18 start-page: 190 year: 2005 ident: 10.1016/j.jcol.2017.11.006_bib0140 article-title: Surgical management of carcinomatosis from colorectal cancer publication-title: Clin Colon Rectal Surg doi: 10.1055/s-2005-916280 contributor: fullname: Sugarbaker – volume: 215 start-page: 781 year: 2004 ident: 10.1016/j.jcol.2017.11.006_bib0230 article-title: Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients publication-title: Ann Oncol doi: 10.1093/annonc/mdh186 contributor: fullname: Elias – volume: 111 start-page: 518 year: 1992 ident: 10.1016/j.jcol.2017.11.006_bib0175 article-title: Proposed classification of complications of surgery with examples of utility in cholecystectomy publication-title: Surgery contributor: fullname: Clavien – volume: 20 start-page: 747 year: 2006 ident: 10.1016/j.jcol.2017.11.006_bib0150 article-title: 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study publication-title: In Vivo contributor: fullname: Cavaliere – volume: 373 start-page: 189 year: 1988 ident: 10.1016/j.jcol.2017.11.006_bib0235 article-title: Surgical management of peritoneal carcinosis: diagnosis, prevention and treatment publication-title: Langenbecks Arch Chir doi: 10.1007/BF01274232 contributor: fullname: Sugarbaker – volume: 43 start-page: 1341 year: 2000 ident: 10.1016/j.jcol.2017.11.006_bib0190 article-title: Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management publication-title: Dis Colon Rectum doi: 10.1007/BF02236627 contributor: fullname: Pestieau – volume: 138 start-page: 26 year: 2003 ident: 10.1016/j.jcol.2017.11.006_bib0245 article-title: Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis publication-title: Arch Surg doi: 10.1001/archsurg.138.1.26 contributor: fullname: Shen – volume: 18 start-page: 204 year: 2005 ident: 10.1016/j.jcol.2017.11.006_bib0195 article-title: Cytoreductive surgery and perioperative intraperitoneal chemotherapy: a new standard of care for appendiceal mucinous tumors with peritoneal dissemination publication-title: Clin Colon Rectal Surg doi: 10.1055/s-2005-916281 contributor: fullname: Sugarbaker |
| SSID | ssj0000652016 ssib022775443 ssib031354472 |
| Score | 2.108353 |
| SecondaryResourceType | review_article |
| Snippet | To evaluate the combined treatment with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from colorectal cancer,... Abstract Introduction To evaluate the combined treatment with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis arising... Introduction To evaluate the combined treatment with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from... Introduction: To evaluate the combined treatment with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from... |
| SourceID | doaj crossref thieme elsevier |
| SourceType | Open Website Aggregation Database Publisher |
| StartPage | 172 |
| SubjectTerms | Cancer colorretal Carcinomatose peritoneal Cirurgia citorredutora Colorectal cancer Cytoreductive surgery Intraperitoneal chemotherapy Peritoneal carcinomatosis Pseudomixoma peritoneal Pseudomyxoma peritonei Quimioterapia intraperitoneal Review Article |
| Title | Peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy |
| URI | https://dx.doi.org/10.1016/j.jcol.2017.11.006 http://dx.doi.org/10.1016/j.jcol.2017.11.006 https://doaj.org/article/9aeace9c106147ca881be68a0e8a13ec |
| Volume | 38 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELagA2JBPEV5yQMTKJDESeyMPFp1ASEeEkJCluM4IpWaVqQd-u-5s9MqLGVhyRBZtnVn33eX3H1HyHmiFIsyuIBCB6EXAQZ6Shfc48aEPObKBLZcbPDCH9_FfQ9pcpatvjAnzNEDO8FdpwpMg0m1DV24VgL8LJMI5RuhAma0tb5-0gqmnA2OAdlsZ7mQcS9lCWsqZlxy1xCkjHld_AopPLHdUQuVLHn_b3CafpVmZFrI098mW43LSG_cVnfImql2ycZD81N8j3w-wSlCTm0YpLE1UDUGN3RclzW1aeQmp_i1leo5xNfI1IoWjtauHpqqKqclfuGdtGb5MqOmMmu-T976vde7gdd0TfA0g-DBQwZ5X8UFRiZxHuoU7F0GsG4CrBgHdAc15DrKMgGRX5IUIc9yIXJuVOCzLFDsgHQqWO2QUBXFhXUglV9EhZ-BNxaBcgU6VQnjrEsuF1KTE0eOIRdZY0OJMpYoY4gyJMi4S25RsMuRSGxtX4C6ZaNu-Ze6uyReqEU2PoLDfpiqXLn4hdOhbO5ovWLw0X_s9JhswpTCpZWdkM70e2ZOyXqdz87sWYXnR_z8A4rI7Wo |
| link.rule.ids | 315,782,786,866,2106,27933,27934 |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Peritoneal+carcinomatosis+treated+with+cytoreductive+surgery+and+intraperitoneal+chemotherapy&rft.jtitle=Journal+of+Coloproctology&rft.au=Hanan%2C+Bernardo&rft.au=Fonseca%2C+Leonardo+Maciel&rft.au=Profeta+da+Luz%2C+Magda+Maria&rft.au=Lacerda-Filho%2C+Ant%C3%B4nio&rft.date=2018-06-01&rft.pub=Elsevier+Editora+Ltda&rft.issn=2237-9363&rft.volume=38&rft.issue=2&rft.spage=172&rft.epage=178&rft_id=info:doi/10.1016%2Fj.jcol.2017.11.006&rft.externalDocID=S2237936317305762 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2237-9363&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2237-9363&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2237-9363&client=summon |